Equities

American Vanguard Corp

American Vanguard Corp

Actions
  • Price (EUR)10.33
  • Today's Change-0.09 / -0.86%
  • Shares traded43.00
  • 1 Year change-40.63%
  • Beta--
Data delayed at least 15 minutes, as of Apr 26 2024 07:04 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

American Vanguard Corporation is a diversified specialty and agricultural products company. The Company develops and markets products for crop protection and management, turf and ornamentals management and public and animal health. The Company conducts its business through its operating subsidiaries, including AMVAC Chemical Corporation (AMVAC) for its domestic business and AMVAC Netherlands BV (AMVAC BV) for its international business. AMVAC manufactures chemical, biological and biorational products that develop and markets solutions for agricultural, commercial and consumer uses. Its products include insecticides, fungicides, herbicides, soil health, plant nutrition, molluscicides, growth regulators, soil fumigants, and biorationals, and are marketed in liquid, powder, and granular forms. AMVAC BV sells products both directly and through its network of subsidiaries in various international territories. It also manufactures microbial cleaning products, BioMop-Plus and DrainGel.

  • Revenue in USD (TTM)579.37m
  • Net income in USD7.52m
  • Incorporated1969
  • Employees845.00
  • Location
    American Vanguard Corp4695 Macarthur CtNEWPORT BEACH 92660-1882United StatesUSA
  • Phone+1 (949) 260-1200
  • Fax+1 (302) 636-5454
  • Websitehttps://www.american-vanguard.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.